You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Details for New Drug Application (NDA): 021269


✉ Email this page to a colleague

« Back to Dashboard


NDA 021269 describes CARDURA XL, which is a drug marketed by Viatris and is included in one NDA. It is available from two suppliers. Additional details are available on the CARDURA XL profile page.

The generic ingredient in CARDURA XL is doxazosin mesylate. There are fourteen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the doxazosin mesylate profile page.
Summary for 021269
Tradename:CARDURA XL
Applicant:Viatris
Ingredient:doxazosin mesylate
Patents:0
Pharmacology for NDA: 021269
Mechanism of ActionAdrenergic alpha-Antagonists
Medical Subject Heading (MeSH) Categories for 021269
Suppliers and Packaging for NDA: 021269
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CARDURA XL doxazosin mesylate TABLET, EXTENDED RELEASE;ORAL 021269 NDA Roerig 0049-2040 0049-2040-10 30 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE (0049-2040-10)
CARDURA XL doxazosin mesylate TABLET, EXTENDED RELEASE;ORAL 021269 NDA Roerig 0049-2080 0049-2080-10 30 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE (0049-2080-10)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrengthEQ 4MG BASE
Approval Date:Feb 22, 2005TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrengthEQ 8MG BASE
Approval Date:Feb 22, 2005TE:RLD:Yes

Expired US Patents for NDA 021269

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Viatris CARDURA XL doxazosin mesylate TABLET, EXTENDED RELEASE;ORAL 021269-002 Feb 22, 2005 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.